Scale Medicine
New York, US · Founded 2023 · Delaware corporation · 1 known investors
Uses AI model of patient biology to predict clinical trial success, fast-tracking cleared drugs to market in 2-3 years.
Founders & leadership
MR
Michael RetchinNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2023
▶$2MraisedDec 2023 · 5 investors · OtherRule 506(b)
▶$2MraisedDec 2023 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael RetchinExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $2M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Scale Medicine do?
- Uses AI model of patient biology to predict clinical trial success, fast-tracking cleared drugs to market in 2-3 years.
- Who are Scale Medicine's investors?
- Scale Medicine's investors include Amino Collective.
- How much funding has Scale Medicine raised?
- Scale Medicine has disclosed $2M raised across 1 round.
- Where is Scale Medicine headquartered?
- Scale Medicine is headquartered in New York, US.